Document is current
Any future updates will be listed below
-
Authors
Laurent, Michaël R. https://orcid.org/0000-0001-9681-8330
Dupont, Jolan https://orcid.org/0000-0001-5336-2791
Lemahieu, Wim https://orcid.org/0000-0003-4893-3240
Jamar, Sofie
Mellaerts, Bea
Dejaeger, Marian https://orcid.org/0000-0002-7289-1397
Gielen, Evelien https://orcid.org/0000-0002-8985-1201
Evenepoel, Pieter https://orcid.org/0000-0002-0797-4321
- License Information
-
More Information
Article History
Accepted: 16 May 2025
First Online: 2 June 2025
Declarations
:
: Dr. Laurent has received consultancy and lecture fees from Alexion, A.M. Pharma, Amgen, AstraZeneca, Galapagos, Kyowa Kirin, Menarini, Orifarm, Pharmanovia, Takeda, Sandoz, UCB and Will Pharma. Dr. Dupont has received consultancy fees and expenses from Daiichi Sankyo and UCB. Dr. Lemahieu has received consultancy fees from Astellas Pharma, Boehringer-Ingelheim and Fresenius Medical. Dr. Jamar has received travel and consultancy fees from Amgen and AstraZeneca. Dr. Mellaerts has no disclosures. Prof. Dejaeger has received research funding from UCB. Prof. Gielen has received consultancy and lecture fees from Amgen, Takeda, UCB. Prof. Evenepoel has received consultancy and lecture fees from Amgen, Fresenius Medical, Vifor, UCB, Takeda, and travel expenses from GSK.
